Cargando…
Finding the optimal regimen for short-term daily recombinant human erythropoietin treatment for blood-saving purpose in patients undergoing unilateral primary total hip arthroplasty: a double-blinded randomized placebo-controlled trial
PURPOSE: To find the best short-term daily recombinant human erythropoietin (rhEPO)-based treatment protocols for blood-saving purpose in THA. METHOD: The patients were randomized to 1 of 3 interventions: Patients in group A received 10,000 IU (150 IU/kg) of subcutaneous rhEPO (1 ml) daily from 5 da...
Autores principales: | Yuan, Mingcheng, Tao, Qifeng, Wang, Duan, Wang, Haoyang, Zhou, Zongke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917634/ https://www.ncbi.nlm.nih.gov/pubmed/35279105 http://dx.doi.org/10.1186/s12891-022-05184-1 |
Ejemplares similares
-
Analgesic effect of single-shot ropivacaine at different layers of the surgical site in primary total hip arthroplasty: a randomised, controlled, observer-blinded study
por: Xiao, Qiang, et al.
Publicado: (2021) -
Optimal Handling of the Patella in Tourniquet‐Free Total Knee Arthroplasty: Eversion or Lateral Retraction?
por: Yuan, Mingcheng, et al.
Publicado: (2020) -
Analgesic effect of perioperative duloxetine in patients after total knee arthroplasty: a prospective, randomized, double-blind, placebo-controlled trial
por: Yuan, Mingcheng, et al.
Publicado: (2022) -
Supercapsular percutaneously-assisted total hip (SuperPath) versus mini-incision posterolateral total hip arthroplasty for hip osteoarthritis: a prospective randomized controlled trial
por: Meng, Weikun, et al.
Publicado: (2021) -
Supercapsular percutaneously-assisted total hip (SuperPath) versus posterolateral total hip arthroplasty in bilateral osteonecrosis of the femoral head: a pilot clinical trial
por: Meng, Weikun, et al.
Publicado: (2019)